Literature DB >> 30527836

Pathogenesis of endometriosis: the genetic/epigenetic theory.

Philippe R Koninckx1, Anastasia Ussia2, Leila Adamyan3, Arnaud Wattiez4, Victor Gomel5, Dan C Martin6.   

Abstract

OBJECTIVE: To study the pathophysiology of endometriosis.
DESIGN: Overview of observations on endometriosis.
SETTING: Not applicable. PATIENT(S): None. INTERVENTIONS(S): None. MAIN OUTCOME MEASURE(S): The hypothesis is compatible with all observations. RESULT(S): Endometriosis, endometrium-like tissue outside the uterus, has a variable macroscopic appearance and a poorly understood natural history. It is a hereditary and heterogeneous disease with many biochemical changes in the lesions, which are clonal in origin. It is associated with pain, infertility, adenomyosis, and changes in the junctional zone, placentation, immunology, plasma, peritoneal fluid, and chronic inflammation of the peritoneal cavity. The Sampson hypothesis of implanted endometrial cells following retrograde menstruation, angiogenic spread, lymphogenic spread, or the metaplasia theory cannot explain all observations if metaplasia is defined as cells with reversible changes and an abnormal behavior/morphology due to the abnormal environment. We propose a polygenetic/polyepigenetic mechanism. The set of genetic and epigenetic incidents transmitted at birth could explain the hereditary aspects, the predisposition, and the endometriosis-associated changes in the endometrium, immunology, and placentation. To develop typical, cystic ovarian or deep endometriosis lesions, a variable series of additional transmissible genetic and epigenetic incidents are required to occur in a cell which may vary from endometrial to stem cells. Subtle lesions are viewed as endometrium in a different environment until additional incidents occur. Typical cystic ovarian or deep endometriosis lesions are heterogeneous and represent three different diseases. CONCLUSION(S): The genetic epigenetic theory is compatible with all observations on endometriosis. Implications for treatment and prevention are discussed.
Copyright © 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometriosis; classification; epigenetics; genetics; heredity; pathogenesis

Mesh:

Substances:

Year:  2018        PMID: 30527836     DOI: 10.1016/j.fertnstert.2018.10.013

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  60 in total

Review 1.  Challenges in uncovering non-invasive biomarkers of endometriosis.

Authors:  Quanah J Hudson; Alexandra Perricos; Rene Wenzl; Iveta Yotova
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-04

2.  Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020).

Authors:  Stefanie Burghaus; Sebastian D Schäfer; Matthias W Beckmann; Iris Brandes; Christian Brünahl; Radek Chvatal; Jan Drahoňovský; Wojciech Dudek; Andreas D Ebert; Christine Fahlbusch; Tanja Fehm; Peter Martin Fehr; Carolin C Hack; Winfried Häuser; Katharina Hancke; Volker Heinecke; Lars-Christian Horn; Christian Houbois; Christine Klapp; Heike Kramer; Harald Krentel; Jan Langrehr; Heike Matuschewski; Ines Mayer; Sylvia Mechsner; Andreas Müller; Armelle Müller; Michael Müller; Peter Oppelt; Thomas Papathemelis; Stefan P Renner; Dietmar Schmidt; Andreas Schüring; Karl-Werner Schweppe; Beata Seeber; Friederike Siedentopf; Horia Sirbu; Daniela Soeffge; Kerstin Weidner; Isabella Zraik; Uwe Andreas Ulrich
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

3.  Archimetrosis: the evolution of a disease and its extant presentation : Pathogenesis and pathophysiology of archimetrosis (uterine adenomyosis and endometriosis).

Authors:  Gerhard Leyendecker; Ludwig Wildt; Matthias W Laschke; Gerhard Mall
Journal:  Arch Gynecol Obstet       Date:  2022-05-21       Impact factor: 2.344

4.  Clinical efficacy of turtle shell decocted pills for endometriosis and their influence on cellular immunity.

Authors:  Yunfang Wu; Jichen Zhang; Ting Wang; Kai Lou
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 5.  Endometrioma and assisted reproductive technology: a review.

Authors:  Mira H Kheil; Fady I Sharara; Jean Marc Ayoubi; Sara Rahman; Gaby Moawad
Journal:  J Assist Reprod Genet       Date:  2022-01-24       Impact factor: 3.412

6.  Giant exophytic cystic adenomyosis with a levonorgestrel containing intrauterine device out of the uterine cavity after uterine myomectomy: A case report.

Authors:  Yong Zhou; Zheng-Yun Chen; Xin-Mei Zhang
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

Review 7.  Current Knowledge on Endometriosis Etiology: A Systematic Review of Literature.

Authors:  Lyudmila M Mikhaleva; Victor E Radzinsky; Mekan R Orazov; Tatyana N Khovanskaya; Anastasia V Sorokina; Sergey A Mikhalev; Snezhana V Volkova; Victoria B Shustova; Mikhail Y Sinelnikov
Journal:  Int J Womens Health       Date:  2021-06-01

8.  Effect of combined contraceptive pill on immune cell of ovarian endometriotic tissue.

Authors:  Wanwisa Waiyaput; Keerati Wattanakamolchai; Yada Tingthanatikul; Srithean Lertvikool; Siriluk Tantanavipas; Kanthanadon Dittharot; Morakot Sroyraya; Areepan Sophonsritsuk
Journal:  J Ovarian Res       Date:  2021-05-12       Impact factor: 4.234

9.  Single-cell transcriptomic analysis of endometriosis provides insights into fibroblast fates and immune cell heterogeneity.

Authors:  Junyan Ma; Liqi Zhang; Hong Zhan; Yun Mo; Zuanjie Ren; Anwen Shao; Jun Lin
Journal:  Cell Biosci       Date:  2021-07-07       Impact factor: 7.133

Review 10.  Estrogen- and Progesterone (P4)-Mediated Epigenetic Modifications of Endometrial Stromal Cells (EnSCs) and/or Mesenchymal Stem/Stromal Cells (MSCs) in the Etiopathogenesis of Endometriosis.

Authors:  Dariusz Szukiewicz; Aleksandra Stangret; Carmen Ruiz-Ruiz; Enrique G Olivares; Olga Soriţău; Sergiu Suşman; Grzegorz Szewczyk
Journal:  Stem Cell Rev Rep       Date:  2021-01-07       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.